Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.

[1]  F. Montorsi,et al.  Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series. , 2017, European urology.

[2]  T. Schlomm,et al.  Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy , 2017, BJU international.

[3]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[4]  F. Montorsi,et al.  Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer , 2017, The Journal of urology.

[5]  David Gillatt,et al.  10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.

[6]  A. Wong,et al.  Adjuvant radiation with hormonal therapy is associated with improved survival in men with pathologically involved lymph nodes after radical surgery for prostate cancer. , 2016, Urologic oncology.

[7]  H. G. van der Poel,et al.  The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients. , 2016, European urology.

[8]  Adam P Dicker,et al.  Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. , 2016, The Lancet. Oncology.

[9]  Shree Agrawal,et al.  Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Freedland,et al.  Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy. , 2016, European urology.

[11]  F. Montorsi,et al.  Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in ≥PT2, pN0 Patients With a Comprehensive Tumor Control Probability Model. , 2016, International journal of radiation oncology, biology, physics.

[12]  J. Yaxley,et al.  The use of 68 Ga‐PSMA PET CT in men with biochemical recurrence after definitive treatment of acinar prostate cancer , 2016, BJU international.

[13]  W. Harmsen,et al.  Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Fisher,et al.  Evidence of prostate cancer "reverse stage migration" toward more advanced disease at diagnosis: Data from the Pennsylvania Cancer Registry. , 2016, Urologic oncology.

[15]  B. Dubray,et al.  Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. , 2016, The Lancet. Oncology.

[16]  R. Orecchia,et al.  No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy. , 2016, The British journal of radiology.

[17]  M. Borre,et al.  Salvage radiation therapy following radical prostatectomy. A national Danish study , 2016, Acta oncologica.

[18]  B. Trock,et al.  Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk , 2016, Prostate Cancer and Prostatic Disease.

[19]  P. Stricker,et al.  68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment , 2016, BJU international.

[20]  F. Montorsi,et al.  Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. , 2016, European urology.

[21]  Sender Herschorn,et al.  Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis , 2016, British Medical Journal.

[22]  F. Montorsi,et al.  Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy , 2016, Prostate Cancer and Prostatic Diseases.

[23]  D. Grignon,et al.  NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA. , 2016 .

[24]  H. Sung,et al.  Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy , 2016, International journal of urology : official journal of the Japanese Urological Association.

[25]  P. Wust,et al.  Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  F. Montorsi,et al.  Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival. , 2015, European urology.

[27]  A. Jemal,et al.  Declining Use of Radiotherapy for Adverse Features After Radical Prostatectomy: Results From the National Cancer Data Base. , 2015, European urology.

[28]  F. Montorsi,et al.  The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer , 2015, Current Oncology Reports.

[29]  S. Byun,et al.  Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy , 2015, Strahlentherapie und Onkologie.

[30]  H. Rexer,et al.  Adjuvante Strahlentherapie beim lymphknotenpositiven Prostatakarzinom mit geringer Tumorlast nach radikaler Prostatektomie , 2015, Der Urologe.

[31]  B. Kavanagh,et al.  External Validation of the Benefit of Adjuvant Radiotherapy for Pathologic N1M0 Prostate Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  F. Montorsi,et al.  Penile rehabilitation after radical prostatectomy: does it work? , 2015, Translational andrology and urology.

[33]  T. Hyslop,et al.  Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy. , 2015, International journal of radiation oncology, biology, physics.

[34]  F. Feng,et al.  Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  J. Patard,et al.  Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy. , 2015, Urologic oncology.

[36]  T. Joensuu,et al.  Adjuvant Radiotherapy for Lymph‐node Positive Prostate Cancer , 2015, BJU international.

[37]  T. Hyslop,et al.  Radiation Therapy after Radical Prostatectomy for Prostate Cancer: Evaluation of Complications and Influence of Radiation Timing on Outcomes in a Large, Population-Based Cohort , 2015, PloS one.

[38]  P. Kantoff,et al.  Role of androgen deprivation therapy in early salvage radiation among patients with prostate-specific antigen level of 0.5 or less. , 2015, Clinical genitourinary cancer.

[39]  T. Hyslop,et al.  Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features: Comparative Analysis of Long-term Outcomes , 2015, American journal of clinical oncology.

[40]  C. Rübe,et al.  Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial. , 2015, International journal of radiation oncology, biology, physics.

[41]  F. Montorsi,et al.  Early radiotherapy after radical prostatectomy improves cancer‐specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria , 2015, International journal of urology : official journal of the Japanese Urological Association.

[42]  Cesare Cozzarini,et al.  Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  F. Montorsi,et al.  Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. , 2014, European urology.

[44]  L. Salomon,et al.  Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study , 2014, World Journal of Urology.

[45]  F. Montorsi,et al.  Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. , 2014, European urology.

[46]  F. Montorsi,et al.  The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[47]  C. Catton,et al.  Long-term complications in men who have early or late radiotherapy after radical prostatectomy. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[48]  N. Willich,et al.  Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. , 2014, European urology.

[49]  S. Byun,et al.  Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes , 2014, PloS one.

[50]  F. Feng,et al.  Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy , 2014, International journal of radiation oncology, biology, physics.

[51]  L. Ceriani,et al.  Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis , 2014, Clinical chemistry and laboratory medicine.

[52]  U. Capitanio,et al.  Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. , 2014, European urology.

[53]  T. Wiegel,et al.  Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy , 2014, Strahlentherapie und Onkologie.

[54]  N. Lumen,et al.  Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[55]  H. G. van der Poel,et al.  Salvage radiotherapy after robot-assisted laparoscopic radical prostatectomy. , 2013, Urology.

[56]  R. Mehra,et al.  Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following radical prostatectomy , 2013, Cancer.

[57]  S. Goldenberg,et al.  Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. , 2013, The Journal of urology.

[58]  T. Wiegel,et al.  Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis. , 2013, European urology.

[59]  U. Capitanio,et al.  Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. , 2013, European urology.

[60]  S. Lipsitz,et al.  Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy , 2013, BJU international.

[61]  C. Ménard,et al.  Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[62]  L. Collette,et al.  Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) , 2012, The Lancet.

[63]  B. Trock,et al.  The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. , 2012, The Journal of urology.

[64]  J. Ciezki,et al.  Twenty-year Competing Risk Analysis of Secondary Malignancies After External Beam Radiation for Postoperative Treatment of Prostate Cancer Patients From the SEER Database , 2012 .

[65]  P. Scardino,et al.  Long-term outcomes after high-dose postprostatectomy salvage radiation treatment. , 2012, International journal of radiation oncology, biology, physics.

[66]  C. King.  The timing of salvage radiotherapy after radical prostatectomy: a systematic review. , 2012, International journal of radiation oncology, biology, physics.

[67]  T. Guzzo,et al.  Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. , 2012, International journal of radiation oncology, biology, physics.

[68]  F. Montorsi,et al.  High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy. , 2012, International journal of radiation oncology, biology, physics.

[69]  T. Wiegel,et al.  Salvage radiotherapy after prostatectomy - what is the best time to treat? , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[70]  B. Guillonneau,et al.  A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. , 2012, European urology.

[71]  A. Dicker,et al.  Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling. , 2012, European journal of cancer.

[72]  P. Span,et al.  High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy. , 2012, International journal of radiation oncology, biology, physics.

[73]  A. Zietman,et al.  Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. , 2012, European urology.

[74]  H. Sandler,et al.  Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients. , 2012, International journal of radiation oncology, biology, physics.

[75]  U. Capitanio,et al.  Preoperative erectile function represents a significant predictor of postoperative urinary continence recovery in patients treated with bilateral nerve sparing radical prostatectomy. , 2012, The Journal of urology.

[76]  B. Hickey,et al.  Adjuvant radiotherapy following radical prostatectomy for prostate cancer. , 2011, The Cochrane database of systematic reviews.

[77]  P. Scardino,et al.  Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. , 2011, European urology.

[78]  K. Jingu,et al.  Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml , 2011, Radiation oncology.

[79]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[80]  N. Lumen,et al.  High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results. , 2011, European urology.

[81]  A. D'Amico,et al.  Salvage radiation in men after prostate‐specific antigen failure and the risk of death , 2011, Cancer.

[82]  V. Fonteyne,et al.  A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer. , 2011, International journal of radiation oncology, biology, physics.

[83]  T. Wiegel,et al.  Dose Escalation for Patients with Decreasing PSA during Radiotherapy for Elevated PSA after Radical Prostatectomy Improves Biochemical Progression-Free Survival , 2011, Strahlentherapie und Onkologie.

[84]  M. Ritter,et al.  Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence , 2011, Cancer.

[85]  U. Capitanio,et al.  Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. , 2011, European urology.

[86]  B. Trock,et al.  Causes of death after radical prostatectomy at a large tertiary center. , 2011, The Journal of urology.

[87]  L. Kiemeney,et al.  Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[88]  C. Perneel,et al.  A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[89]  A. D'Amico,et al.  Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death , 2010, BJU international.

[90]  Anurag K. Singh,et al.  Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis. , 2010, International journal of radiation oncology, biology, physics.

[91]  T. Wiegel,et al.  Salvage Radiotherapy in Patients with Prostate Cancer and Biochemical Relapse after Radical Prostatectomy: Long-term Follow-up of a Single Center Survey , 2010 .

[92]  M. Heckman,et al.  Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. , 2010, International journal of radiation oncology, biology, physics.

[93]  F. Montorsi,et al.  Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. , 2009, International journal of radiation oncology, biology, physics.

[94]  C. Fiorino,et al.  IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[95]  M. Terris,et al.  Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database , 2009, BJU international.

[96]  N. Lumen,et al.  Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients. , 2009, European urology.

[97]  I. Reis,et al.  Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data. , 2009, Urology.

[98]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[99]  R. Orecchia,et al.  Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[100]  A. Kibel.  Identification of Patients With Prostate Cancer Who Benefit From Immediate Postoperative Radiotherapy: EORTC 22911 , 2008 .

[101]  Misop Han,et al.  Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. , 2008, JAMA.

[102]  F. Montorsi,et al.  TWO POSITIVE NODES REPRESENT A SIGNIFICANT CUT-OFF VALUE FOR CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER. A NEW PROPOSAL BASED ON A TWO INSTITUTION EXPERIENCE ON 784 CONSECUTIVE N+ PATIENTS , 2008 .

[103]  S. Hancock,et al.  Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients. , 2007, International journal of radiation oncology, biology, physics.

[104]  Richard K Valicenti,et al.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[105]  M. Parmar,et al.  RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery). , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[106]  E. Messing,et al.  Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. , 2006, JAMA.

[107]  Daniel W. Miller,et al.  Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. , 2005, JAMA.

[108]  M. Piérart,et al.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) , 2005, The Lancet.

[109]  Steve P Lee,et al.  Effect of pelvic lymph node irradiation in salvage therapy for patients with prostate cancer with a biochemical relapse following radical prostatectomy. , 2004, Clinical prostate cancer.

[110]  J. Moul,et al.  Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. , 2003, Urology.

[111]  M. Menon,et al.  Population‐Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients , 2017, The Prostate.

[112]  A. Vickers,et al.  Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes. , 2016, European urology.

[113]  H. Sandler,et al.  Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. , 2016, European urology.

[114]  P. Scardino,et al.  Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. , 2014, European urology.

[115]  M. Anscher,et al.  Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy , 2013, Cancer.

[116]  F. Montorsi,et al.  Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients. , 2012, International journal of radiation oncology, biology, physics.

[117]  L. Livi,et al.  Adjuvant and salvage radiotherapy after prostatectomy: outcome analysis of 307 patients with prostate cancer , 2012, Journal of Cancer Research and Clinical Oncology.

[118]  C. Lawton.  Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial , 2010 .

[119]  I. Thompson,et al.  Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[120]  A. Kibel.  Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794 , 2008 .

[121]  R. Ackermann.  Postoperative Radiotherapy After Radical Prostatectomy: A Randomised Controlled Trial (EORTC trial 22911) , 2006 .